94 related articles for article (PubMed ID: 29709729)
1. Smoking and FGFR2 rs2981582 variant independently modulate male breast cancer survival: A population-based study in Tuscany, Italy.
Zanna I; Silvestri V; Palli D; Magrini A; Rizzolo P; Saieva C; Zelli V; Bendinelli B; Vezzosi V; Valentini V; Bianchi S; Ottini L; Masala G
Breast; 2018 Aug; 40():85-91. PubMed ID: 29709729
[TBL] [Abstract][Full Text] [Related]
2. Association between the BRCA2 N372H variant and male breast cancer risk: a population-based case-control study in Tuscany, Central Italy.
Palli D; Falchetti M; Masala G; Lupi R; Sera F; Saieva C; D'Amico C; Ceroti M; Rizzolo P; Caligo MA; Zanna I; Ottini L
BMC Cancer; 2007 Sep; 7():170. PubMed ID: 17767707
[TBL] [Abstract][Full Text] [Related]
3. Association of low-penetrance alleles with male breast cancer risk and clinicopathological characteristics: results from a multicenter study in Italy.
Ottini L; Silvestri V; Saieva C; Rizzolo P; Zanna I; Falchetti M; Masala G; Navazio AS; Graziano V; Bianchi S; Manoukian S; Barile M; Peterlongo P; D'Amico C; Varesco L; Tommasi S; Russo A; Giannini G; Cortesi L; Viel A; Montagna M; Radice P; Palli D
Breast Cancer Res Treat; 2013 Apr; 138(3):861-8. PubMed ID: 23468243
[TBL] [Abstract][Full Text] [Related]
4. BRCA1/BRCA2 mutation status and clinical-pathologic features of 108 male breast cancer cases from Tuscany: a population-based study in central Italy.
Ottini L; Rizzolo P; Zanna I; Falchetti M; Masala G; Ceccarelli K; Vezzosi V; Gulino A; Giannini G; Bianchi S; Sera F; Palli D
Breast Cancer Res Treat; 2009 Aug; 116(3):577-86. PubMed ID: 18819001
[TBL] [Abstract][Full Text] [Related]
5. Novel and known genetic variants for male breast cancer risk at 8q24.21, 9p21.3, 11q13.3 and 14q24.1: results from a multicenter study in Italy.
Silvestri V; Rizzolo P; Scarnò M; Chillemi G; Navazio AS; Valentini V; Zelli V; Zanna I; Saieva C; Masala G; Bianchi S; Manoukian S; Barile M; Pensotti V; Peterlongo P; Varesco L; Tommasi S; Russo A; Giannini G; Cortesi L; Viel A; Montagna M; Radice P; Palli D; Ottini L
Eur J Cancer; 2015 Nov; 51(16):2289-95. PubMed ID: 26248686
[TBL] [Abstract][Full Text] [Related]
6. Genetic variants in FGFR2 and TNRC9 genes are associated with breast cancer risk in Pakistani women.
Mazhar A; Jamil F; Bashir Q; Ahmad MS; Masood M; Tanvir I; Rashid N; Waheed A; Afzal MN; Tariq MA
Mol Med Rep; 2016 Oct; 14(4):3443-51. PubMed ID: 27572905
[TBL] [Abstract][Full Text] [Related]
7. Clinical and pathologic characteristics of BRCA-positive and BRCA-negative male breast cancer patients: results from a collaborative multicenter study in Italy.
Ottini L; Silvestri V; Rizzolo P; Falchetti M; Zanna I; Saieva C; Masala G; Bianchi S; Manoukian S; Barile M; Peterlongo P; Varesco L; Tommasi S; Russo A; Giannini G; Cortesi L; Viel A; Montagna M; Radice P; Palli D
Breast Cancer Res Treat; 2012 Jul; 134(1):411-8. PubMed ID: 22527108
[TBL] [Abstract][Full Text] [Related]
8. Association between FGFR2 (rs2981582, rs2420946 and rs2981578) polymorphism and breast cancer susceptibility: a meta-analysis.
Zhang Y; Zeng X; Liu P; Hong R; Lu H; Ji H; Lu L; Li Y
Oncotarget; 2017 Jan; 8(2):3454-3470. PubMed ID: 27966449
[TBL] [Abstract][Full Text] [Related]
9. Association between rs2981582 polymorphism in the FGFR2 gene and the risk of breast cancer in Mexican women.
Murillo-Zamora E; Moreno-Macías H; Ziv E; Romieu I; Lazcano-Ponce E; Angeles-Llerenas A; Pérez-Rodríguez E; Vidal-Millán S; Fejerman L; Torres-Mejía G
Arch Med Res; 2013 Aug; 44(6):459-66. PubMed ID: 24054997
[TBL] [Abstract][Full Text] [Related]
10. Genetic variants in FGFR2 and MAP3K1 are associated with the risk of familial and early-onset breast cancer in a South-American population.
Jara L; Gonzalez-Hormazabal P; Cerceño K; Di Capua GA; Reyes JM; Blanco R; Bravo T; Peralta O; Gomez F; Waugh E; Margarit S; Ibañez G; Romero C; Pakomio J; Roizen G
Breast Cancer Res Treat; 2013 Jan; 137(2):559-69. PubMed ID: 23225170
[TBL] [Abstract][Full Text] [Related]
11. Insight into genetic susceptibility to male breast cancer by multigene panel testing: Results from a multicenter study in Italy.
Rizzolo P; Zelli V; Silvestri V; Valentini V; Zanna I; Bianchi S; Masala G; Spinelli AM; Tibiletti MG; Russo A; Varesco L; Giannini G; Capalbo C; Calistri D; Cortesi L; Viel A; Bonanni B; Azzollini J; Manoukian S; Montagna M; Peterlongo P; Radice P; Palli D; Ottini L
Int J Cancer; 2019 Jul; 145(2):390-400. PubMed ID: 30613976
[TBL] [Abstract][Full Text] [Related]
12. Association of physical activity and polymorphisms in FGFR2 and DNA methylation related genes with breast cancer risk.
Xi J; Su Y; Beeghly Fadiel A; Lin Y; Su FX; Jia WH; Tang LY; Ren ZF
Cancer Epidemiol; 2014 Dec; 38(6):708-14. PubMed ID: 25270516
[TBL] [Abstract][Full Text] [Related]
13. BRCA1 and BRCA2 mutation status and tumor characteristics in male breast cancer: a population-based study in Italy.
Ottini L; Masala G; D'Amico C; Mancini B; Saieva C; Aceto G; Gestri D; Vezzosi V; Falchetti M; De Marco M; Paglierani M; Cama A; Bianchi S; Mariani-Costantini R; Palli D
Cancer Res; 2003 Jan; 63(2):342-7. PubMed ID: 12543786
[TBL] [Abstract][Full Text] [Related]
14. A Prognostic Analysis of Male Breast Cancer (MBC) Compared with Post-Menopausal Female Breast Cancer (FBC).
Yu XF; Yang HJ; Yu Y; Zou DH; Miao LL
PLoS One; 2015; 10(8):e0136670. PubMed ID: 26313461
[TBL] [Abstract][Full Text] [Related]
15. Associations of polymorphisms in the genes of FGFR2, FGF1, and RBFOX2 with breast cancer risk by estrogen/progesterone receptor status.
Cen YL; Qi ML; Li HG; Su Y; Chen LJ; Lin Y; Chen WQ; Xie XM; Tang LY; Ren ZF
Mol Carcinog; 2013 Nov; 52 Suppl 1():E52-9. PubMed ID: 23143756
[TBL] [Abstract][Full Text] [Related]
16. An investigation of the effects of FGFR2 and B7-H4 polymorphisms in breast cancer.
Ozgöz A; Samli H; Oztürk KH; Orhan B; Icduygu FM; Aktepe F; Imirzalioglu N
J Cancer Res Ther; 2013; 9(3):370-5. PubMed ID: 24125968
[TBL] [Abstract][Full Text] [Related]
17. FGFR2 intronic SNPs and breast cancer risk: associations with tumor characteristics and interactions with exogenous exposures and other known breast cancer risk factors.
Marian C; Ochs-Balcom HM; Nie J; Kallakury BV; Ambrosone CB; Trevisan M; Edge S; Shields PG; Freudenheim JL
Int J Cancer; 2011 Aug; 129(3):702-12. PubMed ID: 20853316
[TBL] [Abstract][Full Text] [Related]
18. Male breast cancer in a multi-gene panel testing cohort: insights and unexpected results.
Pritzlaff M; Summerour P; McFarland R; Li S; Reineke P; Dolinsky JS; Goldgar DE; Shimelis H; Couch FJ; Chao EC; LaDuca H
Breast Cancer Res Treat; 2017 Feb; 161(3):575-586. PubMed ID: 28008555
[TBL] [Abstract][Full Text] [Related]
19. Breast cancer susceptibility variants alter risks in familial disease.
Latif A; Hadfield KD; Roberts SA; Shenton A; Lalloo F; Black GC; Howell A; Evans DG; Newman WG
J Med Genet; 2010 Feb; 47(2):126-31. PubMed ID: 19617217
[TBL] [Abstract][Full Text] [Related]
20. Genome-wide association study of susceptibility loci for breast cancer in Sardinian population.
Palomba G; Loi A; Porcu E; Cossu A; Zara I; Budroni M; Dei M; Lai S; Mulas A; Olmeo N; Ionta MT; Atzori F; Cuccuru G; Pitzalis M; Zoledziewska M; Olla N; Lovicu M; Pisano M; Abecasis GR; Uda M; Tanda F; Michailidou K; Easton DF; Chanock SJ; Hoover RN; Hunter DJ; Schlessinger D; Sanna S; Crisponi L; Palmieri G
BMC Cancer; 2015 May; 15():383. PubMed ID: 25956309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]